ADIM
PGNY icon

Alpha DNA Investment Management’s Progyny PGNY Stock Holding History

Alpha DNA Investment Management’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19,639
Closed -$773K – 211
2023
Q2 		$773K Buy
+19,639
New +$709K 0.26% 110

Other funds holding PGNY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alpha DNA Investment Management's PGNY Position: Q3 2023 in Review

Alpha DNA Investment Management sold out of Progyny (PGNY) in Q3 2023, closing a stake of 19,639 shares — an estimated $773K sold.

Alpha DNA Investment Management first reported a position in PGNY in Q2 2023 and held it in 1 quarter. The position peaked at $773K in Q2 2023. 321 funds tracked by Wall St. Rank hold PGNY as of Q3 2023.

  • Alpha DNA Investment Management reported no remaining Progyny position as of Q3 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 19,639 Progyny shares in Q3 2023, an estimated $773K.
  • Alpha DNA Investment Management first reported a position in Progyny in Q2 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's Progyny position peaked at $773K in Q2 2023.
  • 321 funds tracked by Wall St. Rank held Progyny as of Q3 2023.

Based on Alpha DNA Investment Management's 13F filing for Q3 2023, filed 7 Nov 2023.